William J. Febbo
Net Worth

Last updated:

What is William J. Febbo net worth?

The estimated net worth of Mr. William J. Febbo is at least $27,092,589 as of 12 Dec 2024. He owns shares worth $9,439,672 as insider, has earned $12,013,607 from insider trading and has received compensation worth at least $5,639,310 in OptimizeRx Corporation.

What is the salary of William J. Febbo?

Mr. William J. Febbo salary is $626,590 per year as Chief Executive Officer & Director in OptimizeRx Corporation.

How old is William J. Febbo?

Mr. William J. Febbo is 56 years old, born in 1969.

What stocks does William J. Febbo currently own?

As insider, Mr. William J. Febbo owns shares in one company:

Company Title Shares Price per share Total value
OptimizeRx Corporation (OPRX) Chief Executive Officer & Director 601,253 $15.7 $9,439,672

What does OptimizeRx Corporation do?

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

OPRX logo
OPRX
OptimizeRx Corporation
$15.7

William J. Febbo insider trading

OptimizeRx Corporation

Mr. William J. Febbo has made 9 insider trades between 2016-2024, according to the Form 4 filled with the SEC. Most recently he purchased 20,000 units of OPRX stock worth $100,220 on 12 Dec 2024.

The largest trade he's ever made was exercising 394,739 units of OPRX stock on 25 Mar 2021. As of 12 Dec 2024 he still owns at least 601,253 units of OPRX stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 20,000 $5.01 $100,220
Option
Restricted Stock Units 9,628 N/A N/A
Option
Common Stock 9,628 N/A N/A
Option
Common Stock 9,628 N/A N/A
Option
Restricted Stock Units 9,628 N/A N/A
Purchase
Common Stock 10,700 $15.29 $163,646
Purchase
Common Stock 5,400 $16.18 $87,367
Sale
Common Stock 16,666 $44.15 $735,871
Sale
Common Stock 16,666 $47.67 $794,468
Sale
Common Stock (pursuant to 10B5-1 plan) 16,666 $54.55 $909,130
Sale
Common Stock (pursuant to 10B5-1 plan) 16,666 $82.18 $1,369,612
Sale
Common Stock (pursuant to 10B5-1 plan) 16,666 $84.2 $1,403,277
Sale
Common Stock (pursuant to 10B5-1 plan) 16,666 $65.74 $1,095,623
Sale
Common Stock (pursuant to 10B5-1 plan) 16,666 $60.46 $1,007,626
Sale
Common Stock 80,000 $46.1 $3,688,000
Option
Stock Option 394,739 $3.21 $1,267,112
Option
Common Stock 394,739 $3.21 $1,267,112
Sale
Common Stock 20,000 $50.5 $1,010,000
Option
Common Stock 21,186 N/A N/A
Option
Unvested Restricted Stock Award 21,186 N/A N/A
Option
Unvested Restricted Stock Award 21,186 N/A N/A
Option
Common Stock 21,186 N/A N/A
Option
Unvested Restricted Stock Award 21,187 N/A N/A
Option
Common Stock 21,187 N/A N/A
Option
Stock Option 45,261 $3.21 $145,288
Option
Common Stock 45,261 $3.21 $145,288
Option
Common Stock 21,187 N/A N/A
Option
Unvested Restricted Stock Award 21,187 N/A N/A
Option
Common Stock 30,000 $3.21 $96,300
Option
Stock Option 30,000 $3.21 $96,300
Option
Common Stock 30,000 N/A N/A
Option
Stock Option 30,000 N/A N/A
Purchase
Common Stock 5,000 N/A N/A
Purchase
Common Stock 2,000 N/A N/A
Purchase
Common Stock 600 N/A N/A
Purchase
Common Stock 1,000 N/A N/A
Purchase
Common Stock 4,000 N/A N/A
Purchase
Common Stock 9,000 N/A N/A
Purchase
Common Stock 21,567 N/A N/A
Purchase
Common Stock 21,567 N/A N/A

OptimizeRx key executives

OptimizeRx Corporation executives and other stock owners filed with the SEC: